secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001171843-25-003935
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose obtains CEO cash advance; warns of possible insolvency without additional funding in coming days
--------------------------------------------------------------------------------

- CEO William Rice provides non-interest bearing, unsecured short-term cash advance to support payroll and obligations.
- Company warns it may not have sufficient resources and could enter insolvency proceedings without additional funding in coming days.
- Director Carol Ashe resigned effective June 16, 2025.
- Advance is a related-party transaction exempt from formal valuation and minority approval under MI 61-101.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000117184325003935/0001171843-25-003935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000117184325003935/f6k_061725.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-003935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer